Capacity & access
Facility inventories, ICU capacity, workforce distribution and population travel-time analysis.
CRITICAL CARE · POLICY & HEALTH-SYSTEMS ENGINEERING
Global Critical Care Observatory
Turn critical-care data into decisions about capacity, access and patient outcomes.
A policy and health-systems engineering initiative evaluating geographic access to intensive care globally. We map ICU capacity and population travel times to identify underserved areas, prioritize investment, strengthen referral networks and support accountable health-system planning.
POLICY & HEALTH-SYSTEMS ENGINEERING
Map capacity. Evaluate access. Inform system design.
Clinical research
Observational studies, real-world outcomes and protocol-led collaborative clinical research.
Decision support
Translate accessibility estimates into priority expansion scenarios, referral-network design, regional policy briefs and dialogue with health authorities.
FOUNDATIONAL EVIDENCE · COLOMBIA
Preprint · Under peer review in Scientific ReportsProlonged travel time to intensive care in Colombia: a national analysis to inform critical care policy and network design
This study evaluates population-level travel-time access to intensive-care services across Colombia and identifies areas with prolonged geographic access to inform critical-care policy, service planning, and network design.
Principal investigators
Dr. Joseph L. Nates · Dr. Agamenón Quintero Villarreal · Jorge Racedo
Editorial status confirmed by programme leadership, 28 September 2026. Peer review is ongoing; the preprint is not an accepted journal article.
Quintero Villarreal A, Nates JL, Camargo-Assis F, et al. Research Square, 2026.
DOI: 10.21203/rs.3.rs-10233105/v1
Scientific Reports ↗
Springer Nature
Journal-level metric, not a manuscript assessment. Submission or review does not imply acceptance.Know the collaboration before you join.
Protocols, participating institutions, roles, data rights, IP and economic arrangements are documented for each project and may require negotiation with investigators and stakeholders.
Review the scientific collaboration framework →EVIDENCE & OUTPUTS
Additional clinical evidence
Submitted
Prediction Models for Mortality in Critically Ill Obstetric Patients: A Systematic Review and Risk-of-Bias Assessment
Principal investigators
Dr. Joseph L. Nates · Jorge Racedo
A systematic review examining mortality prediction models in critically ill obstetric patients and assessing risk of bias in the underlying studies.
Manuscript findings
- 41 studies
- 109 model evaluations and 65 score variants. Search through 25 April 2026.
- 34%
- Evaluations reporting calibration. General ICU models had median AUROCs of 0.82–0.87, but frequently overestimated mortality.
Interpretation & limitations
Heterogeneity precluded quantitative pooling. Discrimination does not guarantee calibrated probabilities. Validation and recalibration are needed before using these models for individual decisions.
Summary of a submitted manuscript, not yet accepted.
Critical Care Medicine ↗
Lippincott Williams & Wilkins · Wolters Kluwer
Journal-level metric, not a manuscript assessment. Submission or review does not imply acceptance.View evidence record →
No public preprint or journal article is linked in the verified register.
Submitted
Rural–urban differences in obstetric intensive care in Colombia
Principal investigators
Dr. Francisco Camargo-Assis
This study evaluates rural–urban differences in obstetric intensive-care admission, organ support, resource use, and maternal–fetal outcomes within a Colombian hospital cohort from 2014 through 2018.
Manuscript findings
- 257 patients
- 103 rural and 154 urban; one referral obstetric ICU in Montería, Colombia, 2014–2018.
- Invasive ventilation
- 9.7% rural vs. 3.2% urban. Crude RR 2.99; 95% CI 1.05–8.50.
- Red-cell transfusion
- 23.3% rural vs. 12.3% urban. Crude RR 1.89; 95% CI 1.09–3.27.
Interpretation & limitations
Exploratory, unadjusted, single-center complete-case comparisons; 52 of 309 admissions were excluded. Deaths were too few for reliable comparisons. Findings do not establish causality or population-level ICU access; they motivate research on referral and pretransfer care.
Summary of a submitted manuscript, not yet accepted.
BMC Pregnancy and Childbirth ↗
BioMed Central · Springer Nature
Journal-level metric, not a manuscript assessment. Submission or review does not imply acceptance.View evidence record →
No public preprint or journal article is linked in the verified register.
ONGOING REGIONAL WORK
Regional reach. Clinical leadership.
21 regional ICU mapping projects and one adult critical-care phototherapy pilot, listed in the microscopIA project catalogue.
22listed projects
22 projects shown
Andean & Northern South America
Part of the global evaluation of ICU accessibility: map facilities and capacity, model population travel times, identify underserved areas and inform regional service planning.
Countries & areas (8)
- Bolivia
- Colombia
- Ecuador
- Peru
- Venezuela
- Guyana
- Suriname
- French Guiana
PRINCIPAL INVESTIGATORDr. Joseph L. Nates
Project details & current availability ↗Clinical Expert and Head of the Global ICU Mapping Initiative
Professor and Deputy Department Chair, Department of Critical Care Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Australia & New Zealand
Part of the global evaluation of ICU accessibility: map facilities and capacity, model population travel times, identify underserved areas and inform regional service planning.
Countries & areas (2)
- Australia
- New Zealand
PRINCIPAL INVESTIGATORDr. Joseph L. Nates
Project details & current availability ↗Clinical Expert and Head of the Global ICU Mapping Initiative
Professor and Deputy Department Chair, Department of Critical Care Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Caucasus & Anatolia
Part of the global evaluation of ICU accessibility: map facilities and capacity, model population travel times, identify underserved areas and inform regional service planning.
Countries & areas (4)
- Armenia
- Azerbaijan
- Georgia
- Türkiye
PRINCIPAL INVESTIGATORDr. Joseph L. Nates
Project details & current availability ↗Clinical Expert and Head of the Global ICU Mapping Initiative
Professor and Deputy Department Chair, Department of Critical Care Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Central Africa
Part of the global evaluation of ICU accessibility: map facilities and capacity, model population travel times, identify underserved areas and inform regional service planning.
Countries & areas (9)
- Angola
- Cameroon
- Central African Republic
- Chad
- Congo - Brazzaville
- Congo - Kinshasa
- Equatorial Guinea
- Gabon
- São Tomé & Príncipe
PRINCIPAL INVESTIGATORDr. Joseph L. Nates
Project details & current availability ↗Clinical Expert and Head of the Global ICU Mapping Initiative
Professor and Deputy Department Chair, Department of Critical Care Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Central America & Caribbean
Part of the global evaluation of ICU accessibility: map facilities and capacity, model population travel times, identify underserved areas and inform regional service planning.
Countries & areas (35)
- Belize
- Costa Rica
- El Salvador
- Guatemala
- Honduras
- Nicaragua
- Panama
- Antigua & Barbuda
- Bahamas
- Barbados
- Cuba
- Dominica
- Dominican Republic
- Grenada
- Haiti
- Jamaica
- St. Kitts & Nevis
- St. Lucia
- St. Vincent & Grenadines
- Trinidad & Tobago
- Anguilla
- Aruba
- Caribbean Netherlands
- British Virgin Islands
- Cayman Islands
- Curaçao
- Guadeloupe
- Martinique
- Montserrat
- Puerto Rico
- St. Barthélemy
- St. Martin
- Sint Maarten
- Turks & Caicos Islands
- U.S. Virgin Islands
PRINCIPAL INVESTIGATORDr. Joseph L. Nates
Project details & current availability ↗Clinical Expert and Head of the Global ICU Mapping Initiative
Professor and Deputy Department Chair, Department of Critical Care Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Central Asia
Part of the global evaluation of ICU accessibility: map facilities and capacity, model population travel times, identify underserved areas and inform regional service planning.
Countries & areas (5)
- Kazakhstan
- Kyrgyzstan
- Tajikistan
- Turkmenistan
- Uzbekistan
PRINCIPAL INVESTIGATORDr. Joseph L. Nates
Project details & current availability ↗Clinical Expert and Head of the Global ICU Mapping Initiative
Professor and Deputy Department Chair, Department of Critical Care Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
East Africa & Horn
Part of the global evaluation of ICU accessibility: map facilities and capacity, model population travel times, identify underserved areas and inform regional service planning.
Countries & areas (10)
- Burundi
- Djibouti
- Eritrea
- Ethiopia
- Kenya
- Rwanda
- Somalia
- South Sudan
- Tanzania
- Uganda
PRINCIPAL INVESTIGATORDr. Joseph L. Nates
Project details & current availability ↗Clinical Expert and Head of the Global ICU Mapping Initiative
Professor and Deputy Department Chair, Department of Critical Care Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
East Asia
Part of the global evaluation of ICU accessibility: map facilities and capacity, model population travel times, identify underserved areas and inform regional service planning.
Countries & areas (8)
- China
- Japan
- North Korea
- South Korea
- Mongolia
- Taiwan
- Hong Kong
- Macao
PRINCIPAL INVESTIGATORDr. Joseph L. Nates
Project details & current availability ↗Clinical Expert and Head of the Global ICU Mapping Initiative
Professor and Deputy Department Chair, Department of Critical Care Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Eastern & Southeastern Europe
Part of the global evaluation of ICU accessibility: map facilities and capacity, model population travel times, identify underserved areas and inform regional service planning.
Countries & areas (18)
- Albania
- Belarus
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Czechia
- Hungary
- Moldova
- Montenegro
- North Macedonia
- Poland
- Romania
- Russia
- Serbia
- Slovakia
- Slovenia
- Ukraine
- Kosovo
PRINCIPAL INVESTIGATORDr. Joseph L. Nates
Project details & current availability ↗Clinical Expert and Head of the Global ICU Mapping Initiative
Professor and Deputy Department Chair, Department of Critical Care Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Middle East
Part of the global evaluation of ICU accessibility: map facilities and capacity, model population travel times, identify underserved areas and inform regional service planning.
Countries & areas (15)
- Bahrain
- Cyprus
- Iran
- Iraq
- Israel
- Jordan
- Kuwait
- Lebanon
- Oman
- Palestine
- Qatar
- Saudi Arabia
- Syria
- United Arab Emirates
- Yemen
PRINCIPAL INVESTIGATORDr. Joseph L. Nates
Project details & current availability ↗Clinical Expert and Head of the Global ICU Mapping Initiative
Professor and Deputy Department Chair, Department of Critical Care Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Nordic & Baltic Europe
Part of the global evaluation of ICU accessibility: map facilities and capacity, model population travel times, identify underserved areas and inform regional service planning.
Countries & areas (11)
- Denmark
- Estonia
- Finland
- Iceland
- Latvia
- Lithuania
- Norway
- Sweden
- Faroe Islands
- Åland Islands
- Svalbard & Jan Mayen
PRINCIPAL INVESTIGATORDr. Joseph L. Nates
Project details & current availability ↗Clinical Expert and Head of the Global ICU Mapping Initiative
Professor and Deputy Department Chair, Department of Critical Care Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
North Africa
Part of the global evaluation of ICU accessibility: map facilities and capacity, model population travel times, identify underserved areas and inform regional service planning.
Countries & areas (7)
- Algeria
- Egypt
- Libya
- Morocco
- Sudan
- Tunisia
- Western Sahara
PRINCIPAL INVESTIGATORDr. Joseph L. Nates
Project details & current availability ↗Clinical Expert and Head of the Global ICU Mapping Initiative
Professor and Deputy Department Chair, Department of Critical Care Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
North America
Part of the global evaluation of ICU accessibility: map facilities and capacity, model population travel times, identify underserved areas and inform regional service planning.
Countries & areas (6)
- Canada
- Mexico
- United States
- Greenland
- Bermuda
- St. Pierre & Miquelon
PRINCIPAL INVESTIGATORDr. Joseph L. Nates
Project details & current availability ↗Clinical Expert and Head of the Global ICU Mapping Initiative
Professor and Deputy Department Chair, Department of Critical Care Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Pacific Islands
Part of the global evaluation of ICU accessibility: map facilities and capacity, model population travel times, identify underserved areas and inform regional service planning.
Countries & areas (22)
- Fiji
- Kiribati
- Marshall Islands
- Micronesia
- Nauru
- Palau
- Papua New Guinea
- Samoa
- Solomon Islands
- Tonga
- Tuvalu
- Vanuatu
- Cook Islands
- Niue
- American Samoa
- French Polynesia
- Guam
- New Caledonia
- Northern Mariana Islands
- Pitcairn Islands
- Tokelau
- Wallis & Futuna
PRINCIPAL INVESTIGATORDr. Joseph L. Nates
Project details & current availability ↗Clinical Expert and Head of the Global ICU Mapping Initiative
Professor and Deputy Department Chair, Department of Critical Care Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
South Asia
Part of the global evaluation of ICU accessibility: map facilities and capacity, model population travel times, identify underserved areas and inform regional service planning.
Countries & areas (8)
- Afghanistan
- Bangladesh
- Bhutan
- India
- Maldives
- Nepal
- Pakistan
- Sri Lanka
PRINCIPAL INVESTIGATORDr. Joseph L. Nates
Project details & current availability ↗Clinical Expert and Head of the Global ICU Mapping Initiative
Professor and Deputy Department Chair, Department of Critical Care Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Southeast Asia
Part of the global evaluation of ICU accessibility: map facilities and capacity, model population travel times, identify underserved areas and inform regional service planning.
Countries & areas (11)
- Brunei
- Cambodia
- Indonesia
- Laos
- Malaysia
- Myanmar (Burma)
- Philippines
- Singapore
- Thailand
- Timor-Leste
- Vietnam
PRINCIPAL INVESTIGATORDr. Joseph L. Nates
Project details & current availability ↗Clinical Expert and Head of the Global ICU Mapping Initiative
Professor and Deputy Department Chair, Department of Critical Care Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Southern Africa
Part of the global evaluation of ICU accessibility: map facilities and capacity, model population travel times, identify underserved areas and inform regional service planning.
Countries & areas (15)
- Botswana
- Eswatini
- Lesotho
- Madagascar
- Malawi
- Mauritius
- Mozambique
- Namibia
- Seychelles
- South Africa
- Zambia
- Zimbabwe
- Comoros
- Réunion
- Mayotte
PRINCIPAL INVESTIGATORDr. Joseph L. Nates
Project details & current availability ↗Clinical Expert and Head of the Global ICU Mapping Initiative
Professor and Deputy Department Chair, Department of Critical Care Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Southern Europe
Part of the global evaluation of ICU accessibility: map facilities and capacity, model population travel times, identify underserved areas and inform regional service planning.
Countries & areas (9)
- Andorra
- Greece
- Italy
- Malta
- Portugal
- San Marino
- Spain
- Vatican City
- Gibraltar
PRINCIPAL INVESTIGATORDr. Joseph L. Nates
Project details & current availability ↗Clinical Expert and Head of the Global ICU Mapping Initiative
Professor and Deputy Department Chair, Department of Critical Care Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Southern South America
Part of the global evaluation of ICU accessibility: map facilities and capacity, model population travel times, identify underserved areas and inform regional service planning.
Countries & areas (6)
- Argentina
- Brazil
- Chile
- Paraguay
- Uruguay
- Falkland Islands (Islas Malvinas)
PRINCIPAL INVESTIGATORDr. Joseph L. Nates
Project details & current availability ↗Clinical Expert and Head of the Global ICU Mapping Initiative
Professor and Deputy Department Chair, Department of Critical Care Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
West Africa
Part of the global evaluation of ICU accessibility: map facilities and capacity, model population travel times, identify underserved areas and inform regional service planning.
Countries & areas (17)
- Benin
- Burkina Faso
- Cape Verde
- Côte d’Ivoire
- Gambia
- Ghana
- Guinea
- Guinea-Bissau
- Liberia
- Mali
- Mauritania
- Niger
- Nigeria
- Senegal
- Sierra Leone
- Togo
- St. Helena
PRINCIPAL INVESTIGATORDr. Joseph L. Nates
Project details & current availability ↗Clinical Expert and Head of the Global ICU Mapping Initiative
Professor and Deputy Department Chair, Department of Critical Care Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Western & Central Europe
Part of the global evaluation of ICU accessibility: map facilities and capacity, model population travel times, identify underserved areas and inform regional service planning.
Countries & areas (14)
- Austria
- Belgium
- France
- Germany
- Ireland
- Liechtenstein
- Luxembourg
- Monaco
- Netherlands
- Switzerland
- United Kingdom
- Guernsey
- Jersey
- Isle of Man
PRINCIPAL INVESTIGATORDr. Joseph L. Nates
Project details & current availability ↗Clinical Expert and Head of the Global ICU Mapping Initiative
Professor and Deputy Department Chair, Department of Critical Care Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Pilot Clinical Trial of Phototherapy in Adult Critical Care
Protocol-led investigation of a light-based intervention in adult critical care. Recruitment and intervention require project-specific authorization.
Countries & areas (1)
- Colombia
PRINCIPAL INVESTIGATORSDr. Joseph L. Nates
Project details & current availability ↗Professor and Deputy Department Chair, Department of Critical Care Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Dr. Agamenón Quintero VillarrealHead of the Critical Care Department, IMAT Oncomédica Auna, Montería, Colombia.
Countries and areas define the Observatory’s working geographic scope. These operational groupings are not identical to UN statistical subregions and do not imply completed mapping, local institutional participation or political affiliation. Geographic reference: UN M49
Catalogue reviewed 27 September 2026. A listing is not confirmation of open recruitment, ethics approval or trial registration. Confirm the specific project before applying.
PROFESSIONAL SCIENTIFIC MEMBERSHIP
Lead a clinical question. Develop it with a team.
For specialized practicing clinicians, investigators, policy professionals and other critical-care experts. Admission is overseen by the Executive Director under the Global Critical Care Observatory Membership and Scientific Committee framework.
Executive leadership coordinates admission decisions and scientific review. This professional membership has a separate pathway from the early-career Join a Project programme.
Research development
One case report or case-series development pathway every two active membership months, with methodological and publication support. microscopIA covers approved Observatory publication fees. Journal acceptance and publication dates remain editorial decisions.
Lead an approved review
Propose a systematic review with meta-analysis where appropriate. Approved projects receive an agreed microscopIA team, execution capacity and budget. The proposing member is expected to lead as PI and planned first author, subject to actual contribution and authorship criteria.
Expert collaboration
Apply to ongoing reviews, trials and scoping reviews through the project PI. Members receive priority consideration for expert invitations in Observatory and microscopIA-governed projects; selection depends on expertise, project needs and approvals.
Affiliation & researcher profile
Use the approved Observatory affiliation for authorized work. Receive a microscopIA researcher profile and certificates of verified participation. Support for eligible CvLAC/GrupLAC records is included; Ministry recognition or classification is independently determined.
Research Elite included
All Research Elite benefits are included without a second membership fee, under the applicable booking, availability and eligibility rules. Community pilots, AI, innovation and device projects have separate eligibility and approvals.
50% service discount
Active members receive 50% off microscopIA service fees for their projects outside the Observatory. Request a written quote showing the regular fee, discount, taxes and any third-party costs before commissioning work. Discounts do not stack.
The form is hosted by Google. Submit professional information; do not include identifiable patient data. Privacy
The fee supports scientific development. Authorship requires substantial contribution, intellectual review, final approval and accountability.
FROM APPLICATION TO FIRST PROJECT
An informed decision before any payment.
Apply without paying
Complete the official Google application form. Sign in to a Google account to proceed, and provide your English CV, joint-project proposal, professional role, institution, country, relevant experience and contribution.
Scientific review
Professional suitability, scientific fit, feasibility, ethics, conflicts and available execution capacity are assessed. Incomplete requests receive a request for information rather than a payment invitation.
Written decision within 14 days
The Executive Director replies with a decision or a clearly explained request for missing information within 14 calendar days of receiving the form submission. No payment is due while the application is pending.
Activate after approval
Approved applicants receive activation instructions for the “Global Critical Care Observatory” plan on microscopiatech.com. Review the terms, confirm the monthly total, then activate. Onboarding defines responsibilities and the first project plan.
Open the official application form
If 14 days pass without a reply, request follow-up from the director; administrative concerns may be escalated to jorge.racedo@microscopiatech.com.
BEFORE YOU APPLY
Your questions, answered.
How do I submit my application?
Complete the official Google application form. You must sign in to a Google account. The Executive Director replies within 14 calendar days of receiving your submission. Application is free, and payment follows written admission only.
I already have Research Elite. Do I pay twice?
Research Elite benefits are included in Observatory membership. Before activation, request coordination of your existing subscription so duplicate billing is avoided.
Will my manuscript be accepted by a journal?
Publication support covers approved case-report or case-series development every two active months and approved publication fees. Journal editors decide acceptance and timing independently. Authorship depends on your actual contribution.
What happens after my project proposal is approved?
The Executive Director approves your proposal in writing and notifies microscopIA to initiate execution. Agree a project-specific scope, team, budget, milestones and contribution plan before activities begin. As principal investigator, you are expected to remain involved in scientific decisions, manuscript preparation and revisions.
Can I join an existing study or bring an outside project?
Request access from the study’s principal investigator, describing your expertise and contribution. Outside projects are eligible for a 50% discount on microscopIA service fees through a written quote; third-party costs and taxes are separate.
Is membership the same as donating?
No. Membership requires scientific admission and an active subscription. Donations are voluntary support, confer no membership or authorship, and use a separate one-time contribution route.
FOR CLINICIANS & SCIENTIFIC COLLABORATORS
Bring your expertise. Shape the next question.
Help translate the realities of intensive care into evidence that health systems can act on. We welcome discussions with intensivists, obstetric and oncologic critical-care specialists, nurses, service leaders and methods experts.
Clinical expertise
Define meaningful questions, outcomes and interpretation.
Discuss this contribution →Regional collaboration
Discuss local service mapping, feasibility and institutional coordination.
Discuss this contribution →Methods & policy
Contribute to evidence appraisal, modelling or decision briefs.
Discuss this contribution →WORK WITH THE PROGRAMME
From a research question to a defined scope of work.
Hospitals, universities, health systems and research teams can discuss a defined scientific engagement with microscopIA. Scope, deliverables, milestones, data access and commercial terms are agreed before work begins.
PHILANTHROPY & PARTNERSHIP
Support the work. Expand what is possible.
Individuals, families, institutions and funders can make a one-time contribution or discuss recurring support. Contributions are separate from membership and preserve scientific independence.
From proposal to execution
Every new research project, case report, case series or innovation proposal requires written approval from the corresponding Observatory Executive Director or research group principal investigator. Admission or membership does not replace this approval.
- Submit the aim, methods, proposed team, data, resources and expected outputs to the responsible scientific authority.
- The scientific authority reviews and approves the proposal, documenting its scope and conditions.
- Once approved, the Executive Director or principal investigator notifies microscopIA to initiate execution of the approved project.
- microscopIA coordinates responsibilities, staff, budget, milestones and data/IP agreements. Activities begin with the required ethics, institutional and regulatory permissions in place.
If leadership is vacant, microscopIA coordinates proposal intake and review; execution awaits approval from a formally designated scientific authority.
Protocols and collaboration agreementsGOVERNMENTS, INSTITUTIONS & COMMUNITIES
Turn a health-system need into a programme of work.
Governments & policymakers
Work with microscopIA on access evaluation, capacity planning, economic analysis, evidence synthesis or programme evaluation. Agree the decision question, methods, data, deliverables and timetable.
Discuss a collaboration →Propose an observatory or initiative
Describe the aim, population and geography, unmet need and proposed Executive Director—you may nominate yourself. Include expertise, methods, expected outputs, partners, resources, funding needs and timeline.
Prepare an email proposal →Jorge Racedo · Managing Director
jorge.racedo@microscopiatech.com
Proposals are evaluated before establishing an initiative, appointment or budget. Send a professional summary without identifiable patient information. Discuss recurring support